Oncology - European Medical Journal

Continue

Oncology

Filter
17 Mar 2017

Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management

Geneva, Switzerland, March 17, 2017 – Genomic Health today announced the presentation of 15 abstracts for the Oncotype DX® breast cancer test at the 15th…
14 Mar 2017

Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval

Cambridge, UK, March 13, 2017 – Astex Pharmaceuticals (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small…
13 Mar 2017

Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017

Kraków, Poland, March 13, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology…
8 Mar 2017

German Community of Gynecological Oncology (AGO) Acknowledges MammaPrint in Breast Cancer Guidelines as Having Level 1A Clinical Evidence

Irvine, CA, USA and Amsterdam, the Netherlands, March 08, 2017 – Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics…
3 Mar 2017

Clinical and Preclinical Data on Monalizumab to Be Presented at AACR Annual Meeting 2017

Marseille, France, March 2, 2017 – Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH) today announces that data on monalizumab will be…
14 Feb 2017

Virtual Reality Project Awarded £20 Million in Funding for Cancer Research

CANCER RESEARCH UK has awarded millions in funding to scientists at the University of Cambridge, Cambridge, UK, who will build three-dimensional (3D)…
31 Jan 2017

Database Created to Collect Cancer Mutation Information

RESEARCHERS in the USA have developed a freely accessible database for collecting and interpreting information on cancer genome alterations.
30 Jan 2017

Existing Drug May Halt Spread of Triple-Negative Breast Cancer

THE SPREAD of triple-negative breast cancer may be greatly reduced by utilising an existing class of drugs that has been approved for the treatment of…